Levetiracetam in Meige's syndrome

Acta Neurologica Scandinavica

Volumn 114, Issue 1, 2006, Pages 63-66

  Yardimci, N ^a   Karatas, M ^a   Kilinc, M ^a   Benli, S ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Dystonia; EMG recordings; Levetiracetam; Meige's syndrome

Indexed keywords

AMITRIPTYLINE; BACLOFEN; BIPERIDEN; BOTULINUM TOXIN A; CHLORPROMAZINE; CLONAZEPAM; DIAZEM; DIAZEPAM; ETIRACETAM; MEXILETINE; SULPIRIDE; ZEPRID;

ADULT; ANAMNESIS; ARTICLE; BLEPHAROSPASM; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DYSPHAGIA; DYSTONIA; FACE MUSCLE; FAMILY HISTORY; FEMALE; HISTORY OF MEDICINE; HUMAN; HYPERSALIVATION; MEIGE DISEASE; MINI MENTAL STATE EXAMINATION; SPEECH DISORDER;

ANTICONVULSANTS; BOTULINUM TOXIN TYPE A; BRAIN; DISORDERS OF EXCESSIVE SOMNOLENCE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROMYOGRAPHY; FACIAL MUSCLES; FEMALE; HUMANS; ION CHANNELS; MEIGE SYNDROME; MIDDLE AGED; MOLECULAR CHAPERONES; PIRACETAM; TREATMENT OUTCOME;

EID: 33745028396     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00624.x     Document Type: Article

References (13)

1. Fahn S Marsden CD Calne DB. Classification and investigation of dystonia. In Marsden CD Fahn S, eds. Movement disorders 2. London : Butterworths, 1987 332 58.
2. Meige H. Les convulsions de la face, une forme clinique de convulsion faciale, bilaterale et mediane. Rev Neurol 1910 21 : 437 43.
3. Shorvon SD Lowenthal A Janz O et al. Multi-center, double blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia 2000 41 : 1179 86.
4. Löscher W Richter A. Piracetam and levetiracetam, two pyrrolidone derivatives, exert antidystonic activity in a hamster model of paroxysmal dystonia. Eur J Pharmacol 2000 391 : 251 4.
5. McGavin CL John V Musser WS. Levetiracetam as a treatment for tardive dyskinesia; a case report. Neurology 2003 61 : 419 20.
6. Ruegg SJ Steck AJ Fuhr P. Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome. Neurology 2004 62 : 338.
7. Moller E Werdelin LM Bakke M Dalager T Prytz S Regeur L. Treatment of perioral dystonia with botulinum toxin in 4 cases of Meige's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003 96 : 544 9.
8. Deuschl G Goddemeier C. Spontaneous and reflex activity of facial muscles in dystonia, Parkinson's disease, and in normal subjects. J Neurol Neurosurg Psychiatry 1998 64 : 320 4.
9. Burke RE Fahn S Marsden CD Bressman SB Moskowitz C Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985 35 : 73 7.
10. Ostergaard L Fuglsang-Frederiksen A Sjö O Werdelin L Winhel H. Quantitative EMG in cervical dystonia. Electromyogr Clin Neurophysiol 1996 36 : 179 85.
11. Perucca E. Drugs under clinical trial. In : Eadie MJ Vajda FSE, eds. Antiepileptic drugs: pharmacology and therapeutics. Berlin : Springer, 1999 515 54.
12. Sullivan KL Hauser RA Louis ED Chari G Zesiewicz TA. Levetiracetam for the treatment of generalized dystonia. Parkinsonism Relat Disord 2005 11 : 469 471.
13. Zesiewicz TA Louis ED Sullivan KL Menkin M Dunne PB Hauser RA. Substantial improvement in a Meige's syndrome patient with levetiracetam treatment. Mov Disord 2004 19 : 1518 21.